Dialysis News and Research

Latest Dialysis News and Research

Baxter second-quarter global sales increase 2% to $3.2 billion

Baxter International Inc. today announced its financial results for the second quarter of 2010, reporting earnings in line with the company's previously issued guidance of $0.90 to $0.93 per diluted share.

From Baxter International Inc. 22 Jul 2010

World-first dialysis study set to reduce health costs

The results of a world-first controlled trial of dialysis start-time in patients with Stage V chronic kidney disease is set to have major impact on the cost and infrastructure of chronic kidney disease (CKD) treatment and dialysis services.

20 Jul 2010

Cardiac Science issues update on AED recall announced in November 2009

Cardiac Science Corporation has issued an update to customers affected by a recall first announced by the Company on November 13, 2009.

20 Jul 2010

Cardiac Science addresses outstanding issues relating to corrective AED field action with FDA

Cardiac Science Corporation, a global leader in automated external defibrillator and diagnostic cardiac monitoring devices, announced it has addressed outstanding issues with the Food and Drug Administration relating to the corrective AED field action announced on November 13, 2009.

20 Jul 2010

Mayo Clinic's July issue offers tips on ophthalmology, Alzheimer's and CKD

Here are highlights from the July issue of Mayo Clinic Women's HealthSource. You may cite this publication as often as you wish. Mayo Clinic Women's HealthSource attribution is required.

20 Jul 2010

Researchers discover genetic explanation for non-diabetic kidney disease in African-Americans

Kidney disease is a growing public health problem, with approximately half a million individuals in the United States requiring dialysis treatments to replace the function of their failed kidneys. The problem is particularly acute among African-Americans, whose rates of kidney disease are four times higher than those of European Americans.

20 Jul 2010

NxStage Medical signs 5-year distribution agreement with Spindial

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today announced that it signed a five-year distribution agreement with Spindial S.p.A., a distributor of renal care products, for the promotion, sale, delivery and service of the NxStage System One™ and certain of the Company's in-center products in Italy.

19 Jul 2010

FCC to step up rural broadband for health care

"The U.S. Federal Communications Commission took the first step Thursday toward reworking a US$400 million-a-year program to subsidize telecommunications services to rural health-care facilities, with the new emphasis on broadband. The commission voted unanimously to approve a notice of proposed rulemaking, or NPRM, designed to bring affordable broadband connectivity to more than 2,000 rural hospitals and clinics across the U.S. The purpose of an NPRM is to ask members of the public whether they agree with the proposed changes" (Gross, 7/15).

17 Jul 2010

New research reports evaluating nephrology market in Europe released

BioTrends Research Group, Inc. has released two new syndicated market research reports evaluating the nephrology market in Europe. The reports, TreatmentTrends: Renal Anemia and TreatmentTrends: Bone and Mineral Metabolism, are derived from the responses of over 200 European nephrologists polled in May and June, 2010 regarding their approach to managing renal anemia and bone and mineral disturbances in their dialysis and chronic kidney disease patients.

16 Jul 2010

High blood pressure, diabetes leads to CKD

People with diabetes and high blood pressure need to take care of their kidneys. According to the July issue of Mayo Clinic Women's HealthSource, chronic kidney disease (CKD) is a growing problem in the United States. The most common causes are diabetes and high blood pressure

16 Jul 2010

DaVita to locate new headquarters building in a lot adjacent to Millennium Bridge

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease, announced today it will locate its new headquarters building in a lot adjacent to the Millennium Bridge, at the west end of the 16th Street Mall, across from the new Union Station development. Construction will begin in early 2011 and DaVita expects to begin occupying the building in the second half of 2012.

15 Jul 2010

Study suggests chronic kidney disease affects persons of African, Hispanic heritage at higher rate

Chronic kidney disease affects millions in North America, with persons of African heritage being at a four-fold higher risk and those of Hispanic heritage having a two-fold higher risk compared to the rest of the population. An international study carried out by Dr. Karl Skorecki, from the Technion-Israel Institute of Technology and Rambam Medical Center in Haifa, and his team points to the APOL1 gene as involved in the increased risk of kidney disease in this high-risk population. The results are to be published online in Springer's journal Human Genetics.

15 Jul 2010

Study finds substantial regional variation in treatment practices for older adults with ESRD

There is substantial regional variation in treatment practices for care of older adults with end-stage renal disease, including receipt of hospice care and discontinuation of dialysis before death, according to a study in the July 14 issue of JAMA.

14 Jul 2010

Watson Laboratories files ANDA with FDA for generic Renvela for oral suspension

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market sevelamer carbonate for oral suspension, 0.8g and 2.4g per packet. Watson's sevelamer carbonate for oral suspension product is the generic version of Genzyme's Renvela for Oral Suspension.

13 Jul 2010

APIC survey uncovers barriers in adoption of best practices for CRBSI prevention in hospitals

Hospitals still struggle to prevent avoidable healthcare-associated infections, according to a survey of infection preventionists released today by the Association for Professionals in Infection Control and Epidemiology. Half of those surveyed agree that catheter-related bloodstream infections continue to be a problem in their facilities and cite lack of time, resources, and the commitment of hospital leadership as hindering their ability to combat these infections more aggressively.

13 Jul 2010

Reata funds second pivotal trial of bardoxolone with $78 million equity financing

Reata Pharmaceuticals, Inc. has completed a $78 million equity financing led by existing investors CPMG, Inc. and Novo A/S. This financing brings the total raised by the Company to $180 million since inception.

12 Jul 2010

AngioDynamics adds low-profile, mini models to Smart Port CT family of power-injectable ports

AngioDynamics announced today the global expansion of its Smart Port CT family of power-injectable ports, featuring its patented Vortex® port technology - to include low-profile and mini models for repeated treatments such as chemotherapy and for use with computed tomography (CT).

12 Jul 2010

Rockwell Medical completes End of Phase II meeting with FDA regarding SFP

Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease, chronic kidney disease, and iron deficiency anemia, announced today that it has successfully completed an End of Phase II meeting with the U.S. Food and Drug Administration regarding the Company's lead drug candidate Soluble Ferric Pyrophosphate, a novel continuous iron-replacement therapy designed to treat iron deficiency anemia in hemodialysis patients.

8 Jul 2010

Aethlon Medical files provisional patent on behalf of ESI for exosome detection assay

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it has filed a provisional patent on behalf of its wholly owned subsidiary Exosome Sciences, Inc. (ESI), relating to the development of an assay that will allow researchers to detect exosomes in blood and other fluids.

8 Jul 2010

FDA issues formal response to Nephros' 510(k) application for hemodiafiltration system

Nephros, Inc., a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today reported that the U.S. Food and Drug Administration has issued a formal response to the company's 510(k) application.

8 Jul 2010

Dialysis News and Research

Latest Dialysis News and Research

Baxter second-quarter global sales increase 2% to $3.2 billion

World-first dialysis study set to reduce health costs

Cardiac Science issues update on AED recall announced in November 2009

Cardiac Science addresses outstanding issues relating to corrective AED field action with FDA

Mayo Clinic's July issue offers tips on ophthalmology, Alzheimer's and CKD

Researchers discover genetic explanation for non-diabetic kidney disease in African-Americans

NxStage Medical signs 5-year distribution agreement with Spindial

FCC to step up rural broadband for health care

New research reports evaluating nephrology market in Europe released

High blood pressure, diabetes leads to CKD

DaVita to locate new headquarters building in a lot adjacent to Millennium Bridge

Study suggests chronic kidney disease affects persons of African, Hispanic heritage at higher rate

Study finds substantial regional variation in treatment practices for older adults with ESRD

Watson Laboratories files ANDA with FDA for generic Renvela for oral suspension

APIC survey uncovers barriers in adoption of best practices for CRBSI prevention in hospitals

Reata funds second pivotal trial of bardoxolone with $78 million equity financing

AngioDynamics adds low-profile, mini models to Smart Port CT family of power-injectable ports

Rockwell Medical completes End of Phase II meeting with FDA regarding SFP

Aethlon Medical files provisional patent on behalf of ESI for exosome detection assay

FDA issues formal response to Nephros' 510(k) application for hemodiafiltration system

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dialysis News and Research

Latest Dialysis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in